Taken together, it seems that there are exceptional problems regarding systemic HMGB1 quantification during acute COVID-19, due to yet undefined partner molecules attaching strongly to HMGB1 and causing steric hindrance for antibody recognition. The gene discussed is HMGB1; the disease is COVID-19.